| Jump to: | Authorized Access | | | Attribution | | | Authorized Requests |
- Study Description
-
Important Links and Information
-
Request access via Authorized Access
- Instructions for requestors
- Data Use Certification (DUC) Agreement
- Talking Glossary of Genetic Terms
This study evaluated the multi-omic analysis of endothelial cells with a focus on von Willebrand factor regulation, and investigated aspects of endothelial regulation in the context of blood disorders. The data available at dbGaP consist of multi-omic analyses of these cells.
- Study Design:
- Case-Control
- Study Type:
- Case-Control
- Total number of consented subjects: 36
- Subject Sample Telemetry Report (SSTR)
-
Request access via Authorized Access
- Authorized Access
- Publicly Available Data
- Link to other NCBI resources related to this study
- Study Inclusion/Exclusion Criteria
Inclusion Criteria
1. Patients >= age of 1 with a specific blood disorder:
- a bleeding disorder: Von Willebrand disease (VWD), Hemophilia, or other rare specific coagulation deficiencies
- presence of history of a thrombus: venous thromboembolism, pulmonary embolism, arterial ischemic stroke, etc.
- sickle cell disease, including those with hemoglobin SS, hemoglobin SC, and other combinations resulting in clinical sickle cell disease
- a specific vascular disease: pulmonary hypertension, atherosclerosis, peripheral arterial disease, etc.
- blood dyscrasias or myeloproliferative disorders
2. Direct family members (age 1-99 years) of patients enrolled above.
3. Healthy normal controls to establish a normal range of endothelial-specific outcomes.
- Selected Publications
- Diseases/Traits Related to Study (MeSH terms)
-
- Primary Phenotype: Hematologic Diseases
- Endothelium
- Authorized Data Access Requests
- Study Attribution
-
-
Principal Investigator
- Christopher Ng. Anschutz Medical Campus, University of Colorado, Aurora, CO, USA.
-
Funding Sources
- 1P01HL144457-01. National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA.
- Grant. National Hemophilia Foundation, New York, NY, USA.
- 5 H30 MC00008-20-00. Maternal & Child Health, Health Resources and Services Administration, Bethesda, MD, USA.
-
Principal Investigator